Abstract Library
Members may log into MY ENETS to visit the abstract library from previous ENETS conferences.
Participants of the ENETS Conference in 2024 can now access the abstract booklet, e-posters and videos, slide decks of talks, the poster carousel, and more via My ENETS.
ENETS Abstract Search
#3070 Activity and Safety of Avelumab in Merkel Cell Carcinoma: Our Experience
Introduction: Merkel cell carcinoma (MCC) is an aggressive neuroendocrine carcinoma of the skin. The use of checkpoint inhibitors has shown good results in the treatment of advanced MCC. Avelumab is a PD-L1 inhibitor able to prevent the inactivation of the T lymphocytes. We report a serie of consecutive MCC cases treated with Avelumab in two centres
Conference: 17th Annual ENETSConcerence (2020)
Presenting Author: Giuffrida D
Authors: Puliafito I, Sciacca D, Bonasera A, Blanco G, Iacono F,
Introduction: Neuroendocrine tumors (NETs) are a small heterogeneous group of cancers, developing from the neuroendocrine system. NETs may include functional or non-functional tumors; moreover, they may be familial and have further associated tumors.
Conference: 17th Annual ENETSConcerence (2020)
Presenting Author: Giuffrida D
Authors: Puliafito I, Blanco G, Sciacca D, Colarossi C, Leotta E,
Keywords: neuroendocrine, tumors, our, retrospective, analysis,
#2295 Results of Liver Transplantation in Patients with Neuroendocrine Tumors
Introduction: liver transplantation (LTx) for patients with neuroendocrine tumors (NET) is a option for patients con metastasis limited to the liver. The main indication is when the metastatic NET of the liver not accessible to surgery or reduction.
Conference: 15th Annual ENETSConcerence (2018)
Presenting Author:
Authors: Percovich J, García R, Romero M, Blanco M, Torres G,
Keywords: Liver transplant, Neuroendocine tumors, Time of recurrence,
Introduction: Pancreatic neuroendocrine tumors (PNET) are rare, heterogeneous and challenging neoplasms. Surgical resection is the only curative treatment. Recurrence can occur even after years. Diagnosis of malignancy is difficult so further studies are necessary to identify prognostic criteria.
Conference: 15th Annual ENETSConcerence (2018)
Presenting Author:
Authors: Blanco L, Dopazo C, Pando E, Caralt M, Puértolas N,
Introduction: Advanced neuroendocrine carcinomas (NEC) of the lung are associated with a dismal prognosis and are commonly treated with platinum/etoposide (P/E) regimens. However, few studies evaluated their impact in lung NEC and it is still unclear whether the outcome of such patients (pts) has been improved over the past years (yrs).
Conference: 15th Annual ENETSConcerence (2018)
Presenting Author: Giuffrida D
Authors: Giuffrida D, Chillari F, Blanco G, Russo A, Franchina T,
Keywords: neuroendocrine carcinoma, lung, platinum-etoposide, LCNEC, SCLC, chemotherapy,